For the last four years, we’ve had the privilege of partnering with leading biotech and pharma companies in Boston and beyond to take on some of the toughest challenges in…
I recently had the pleasure of working with Goldfinch to help characterize its high-throughput organoid platform, which it developed for preclinical validation of potential therapies for kidney disease.
Lots of folks in the life sciences are finding themselves suddenly thrown into an involuntary work-from-home situation. Here at Diamond Age we’ve been working remotely from our homes for some…
At Diamond Age Data Science, we make extensive use of RMarkdown and RStudio. These tools let us merge our analyses and reporting into a single framework and give our customers…
We’ll be hosting the venerable Boston Computational Biology and Bioinformatics Meetup in Cambridge, at the Asgard, December 10th. Please come join us for food and drinks and much discussion of…
One of the common analysis tasks we have at Diamond Age is to analyze single cell RNA-seq data. Our customers are largely therapeutics-development biotechs who use this new technology to…
You must be logged in to post a comment.